右心房回收HTK停搏液对小儿心脏术后低钠血症和癫痫的影响
该回顾性研究分析了204例18岁以下先天性心脏病手术患者,比较回收与未回收右心房HTK停搏液流出液对术中血钠水平和术后癫痫发生率的影响。结果显示回收组血钠<130 mEq/L的比例显著低于未回收组,且回收干预独立降低低钠血症风险并减少术后癫痫发生。
要点
- 回收右心房HTK停搏液流出液可独立降低主动脉阻断后血钠<130 mEq/L的风险。
- 未回收组术后癫痫发生率显著高于回收组。
- 术后癫痫患者中87.5%存在血钠<130 mEq/L。
核心结论
- 回收右心房HTK停搏液流出液可独立降低主动脉阻断后血钠波动和低钠血症风险,并与术后癫痫发生率下降相关。
研究设计与样本
- 回顾性分析2016年1月至2018年3月204例18岁以下先天性心脏病手术患者,比较回收组(48例)与未回收组(156例),并行倾向评分匹配队列(n=96)分析。
主要发现
- 全队列中,主动脉阻断后血钠<130 mEq/L在未回收组为70%,回收组为21%(OR 8.8,95%CI 4.1-18.3,P < .0001)。
- 倾向评分匹配队列中,血钠<130 mEq/L在未回收组为77%,回收组为21%(OR 12.8,95%CI 4.8-33.1,P < .0001)。
- 16例术后癫痫患者中,14例(87.5%)血钠<130 mEq/L,2例(12.5%)血钠≥130 mEq/L(OR 5.1,95%CI 1.3-22.8,P = .021)。
- 术后癫痫仅发生在未回收组,全队列P = .02,倾向评分匹配队列P = .041。
- 多因素分析显示回收干预是血钠<130 mEq/L的独立保护因素(OR 0.17,95%CI 0.08-0.36,P = .000)。
临床怎么用
- 在小儿心脏手术使用HTK停搏液时,可考虑回收右心房流出液以降低低钠血症和术后癫痫风险。
局限性
- 本研究为单中心回顾性分析,样本量有限,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Custodiol-HTK cardioplegia (Custodiol-HTK Koheler Chemie, GmbH, Bensheim, Germany) causes fluctuations in serum sodium levels, hyponatremia, and is associated with postoperative seizures. We investigated the influence of scavenging right atrial effluent during delivery on intraoperative serum sodium levels and postoperative seizure incidence in pediatric cardiac surgery patients. METHODS: A total of 204 patients younger than age 18 years undergoing congenital heart surgery between January 2016 and March 2018 were analyzed retrospectively. Serum sodium levels after administration of Custodiol-HTK cardioplegia were compared between the scavenge and nonscavenge groups and then in the propensity score-matched cohort (n = 96). Postoperative seizures were documented clinically and with electroencephalogram findings. Logistic regression models were used to identify the independent predictors of serum sodium level after aortic crossclamp. RESULTS: Of 204 patients, 156 (76.5%) were in the nonscavenge, and 48 (23.5%) in the scavenge groups. A serum sodium level <130 mEq/L after crossclamp and administration of Custodiol-HTK cardioplegia in the nonscavenge group were 70% versus 21% in the scavenge group (odds ratio, 8.8; 95% confidence interval, 4.1-18.3; P < .0001) in the entire cohort, and 77% versus 21% (odds ratio, 12.8; 95% confidence interval, 4.8-33.1; P < .0001) in the propensity score-matched cohort. Of 16 patients experiencing a postoperative seizure, 14 (87.5%) had a sodium level <130 mEq/L and 2 (12.5%) had a sodium level ≥130 mEq/L (odds ratio, 5.1; 95% confidence interval, 1.3-22.8; P = .021) after crossclamp. Postoperative seizures occurred in the nonscavenge group but not the scavenge group in the entire cohort (P = .02) and in the propensity score-matched patients (P = .041). Multivariable analysis of the entire cohort showed that scavenge intervention was an independent factor associated with significantly decreased risk of sodium level <130 mEq/L (odds ratio, 0.17; 95% confidence interval, 0.08-0.36; P = .000). CONCLUSIONS: Right atrial effluent scavenging was protective against fluctuations in serum sodium levels after crossclamp and Custodiol-HTK cardioplegia administration independently in both entire and matched cohort, and was also associated with decreased incidence of postoperative seizures.
引用
- Turner II, Ruzmetov M, Niu J, et al. Scavenging right atrial Bretschneider histidine-tryptophan-ketoglutarate cardioplegia: Impact on hyponatremia and seizures in pediatric cardiac surgery patients. J Thorac Cardiovasc Surg. 2020. PMID: 33036746. doi:10.1016/j.jtcvs.2020.08.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。